Basic Information
LncRNA/CircRNA Name | lncRNA-PRAL |
Synonyms | PRAL, lncRNA-PRAL |
Region | GRCh38_17:6772831-6776116 |
Ensemble | ENSG00000279296 |
Refseq | NA |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | lung cancer |
ICD-0-3 | C34 |
Methods | qPCR, Western blot etc. |
Sample | lung cancer tissues, cell lines (H-125, A549, 95D, NCI-H929, and H1975) |
Expression Pattern | down-regulated |
Function Description | The transcript level of PRAL in human lung cancer was remarkably decreased in vivo compared with their adjacent non-cancerous counterparts, and the protein levels of P53 were accordingly suppressed. Moreover, the expression of PRAL was also decreased in all of the 5 lung cancer cell lines. |
Pubmed ID | 28396580 |
Year | 2017 |
Title | P53 Regulation-Association Long Non-Coding RNA (LncRNA PRAL) Inhibits Cell Proliferation by Regulation of P53 in Human Lung Cancer |
External Links
Links for lncRNA-PRAL | GenBank HGNC NONCODE |
Links for lung cancer | OMIM COSMIC |